Stoeckli S J, Pawlik A B, Lipp M, Huber A, Schmid S
Clinic of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, CH-8091 Zurich, Switzerland.
Arch Otolaryngol Head Neck Surg. 2000 Dec;126(12):1473-7. doi: 10.1001/archotol.126.12.1473.
For larynx preservation, radiotherapy is gaining popularity for primary treatment of laryngeal and hypopharyngeal cancer, reserving surgery for salvage.
To analyze the outcome of salvage surgery after failure of primary radiotherapy.
Nine-year retrospective outcome analysis.
University referral center.
Fifty-four patients with squamous cell carcinoma of the larynx (n = 39) or hypopharynx (n = 15).
For laryngeal cancer, mean interval from radiation to detection of recurrence was 14.5 months (range, 2-66 months). Twenty-three patients (59%) presented with a more advanced tumor stage after radiation than at the initial evaluation. Total laryngectomy was needed in 36 patients (92%). Disease-specific 5-year survival rate was 63%. Survival of patients with small recurrent tumors was statistically significantly better than those with advanced tumors (P =.004). For hypopharyngeal cancer, mean interval from radiation to detection of the recurrence was 10.6 months (range, 3-40 months). Total laryngopharyngectomy was needed in 8 of 9 patients with local recurrrence; neck dissection, in 6 patients with regional recurrence. Disease-specific 5-year survival rate was only 20%. Recurrent tumor and node stages did not influence the outcome. Patients with regional recurrences did no better than those with local ones.
Salvage surgery in laryngeal cancer achieves good results, especially for small recurrences. Because of tumor progression, larynx preservation is seldom possible at the time of salvage. Salvage surgery in hypopharyngeal cancer shows poor survival regardless of tumor stage and despite radical surgical procedures, and can be recommended only for carefully selected patients. Arch Otolaryngol Head Neck Surg. 2000;126:1473-1477
为保留喉功能,放射治疗在喉癌和下咽癌的初始治疗中越来越受欢迎,而将手术作为挽救性治疗手段。
分析初始放疗失败后挽救性手术的结果。
九年回顾性结果分析。
大学转诊中心。
54例喉(n = 39)或下咽(n = 15)鳞状细胞癌患者。
对于喉癌,从放疗至复发检测的平均间隔时间为14.5个月(范围2 - 66个月)。23例患者(59%)放疗后肿瘤分期比初始评估时更晚。36例患者(92%)需要行全喉切除术。疾病特异性5年生存率为63%。复发肿瘤较小的患者生存率在统计学上显著高于肿瘤进展期患者(P = 0.004)。对于下咽癌,从放疗至复发检测的平均间隔时间为10.6个月(范围3 - 40个月)。9例局部复发患者中有8例需要行全喉咽切除术;6例区域复发患者需要行颈部淋巴结清扫术。疾病特异性5年生存率仅为20%。复发肿瘤和淋巴结分期不影响治疗结果。区域复发患者的情况并不优于局部复发患者。
喉癌的挽救性手术取得了良好效果,尤其是对于小复发灶。由于肿瘤进展,挽救性手术时很少能保留喉功能。下咽癌的挽救性手术无论肿瘤分期如何,尽管采取了根治性手术措施,生存率仍很低,仅推荐给经过仔细挑选的患者。《耳鼻喉头颈外科文献》。2000年;126:1473 - 1477